Study Objectives: To identify structural and/or metabolic alterations in patients with sleep-related hypermotor epilepsy (SHE) using magnetic resonance imaging (MRI) and proton MR spectroscopy ( 1 H-MRS). Methods: Nineteen SHE patients (seven males; 34.7 ± 9.7 years, mean age ± standard deviation) and 17 matched healthy volunteers (seven males; 34.0 ± 8.9 years) were included in the study. In all patients, the diagnosis of SHE was confirmed by video-polysomnographic recording of seizures. Semiology, seizure frequency, and therapy were assessed for all patients. For each recruited participant, structural MRI and 1 H-MRS sequences were acquired. 1 H-MRS was performed on two regions of interest: the medial thalamus and the anterior cingulate gyrus. Results: At examination, five patients were seizure free. In the remainder, seizure frequency ranged from yearly to multiple episodes per night. Brain MRI was normal in all patients but one. The ratio of N-acetyl-aspartate/Creatine (NAA/Cr) was significantly reduced in the anterior cingulate cortex in patients compared to controls (p < .05). Thalamic NAA/Cr showed no differences between patients and controls. Regression analysis showed that NAA/Cr in the anterior cingulate gyrus correlated with seizure frequency (p < .05), being lower in patients with higher seizure frequency. Conclusions: Given the absence of structural MR changes, our 1 H-MRS data point to a functional NAA reduction in the cingulate cortex of SHE patients, more severe in those patients with higher seizure frequency and thus supporting the involvement of the anterior mesial structures in the pathophysiology of SHE. Keywords: Epilepsy, Sleep-related Hypermotor Epilepsy, 1 H-MRS, cingulate gyrus, nocturnal frontal lobe epilepsy, Neuroimaging.
INTRODUCTION
Sleep-related hypermotor epilepsy (SHE), previously known as Nocturnal Frontal Lobe Epilepsy, is a peculiar form of focal epilepsy in which seizures, characterized by bizarre motor behavior, appear predominantly in clusters during nonrapid eye movement (NREM) sleep. The clinical features and diagnostic criteria of SHE were recently revised during an international consensus conference. [1] [2] [3] In particular, hyperkinetic seizures suggest the involvement of the orbitofrontal regions, while sustained asymmetric tonic/ dystonic posture is most related to the involvement of the mesial frontal structures. However, epileptogenic zone could be heterogeneous with seizures originating from temporal, insular, or parietal regions, that give rise to ictal manifestations typical of SHE when they spread into the frontal lobe. [1] [2] [3] [4] [5] In a majority of patients, the etiology is unknown. Identified etiologies are heterogeneous and include structural anomalies such as focal cortical dysplasia and genetic causes. 1 In the familial form with autosomal dominant inheritance (ADSHE), 1,2 a genetic heterogeneity is evident with at least six genes playing a causative role in the disorder (CHRNA4, CHRNB2, CHRNA2 KCNT1, DEPDC5, NPRL3). [6] [7] [8] [9] [10] [11] [12] However, only a minority of ADSHE families have mutations in known genes, and the clinical features of familial and sporadic cases are similar. [1] [2] [3] 6 Besides cortical areas, different subcortical structures play a role in SHE pathophysiology. 13 In fact, functional imaging in patients affected by ADSHE disclosed abnormalities in the arousal promoting cholinergic system and in basal ganglia. Positron emission tomography studies reported high density of acetylcholine receptors in the epithalamus, suggesting an upregulation of mesopontine arousal system, 14 whereas a reduced striatal D1 receptor binding that could reflect an elevation of extracellular dopamine level or loss of striatal neurons has been documented. 15 Most of the SHE seizures occur in the early stages of NREM sleep, and electroencephalography (EEG) discharge onset might coincide with physiological sleep transients (as K-complex or periodic arousals), supporting the hypothesis that thalamocortical projections, which normally drive the physiological sleep transients, may trigger the epileptic foci. 3 The mesial surface of hemisphere, the thalamus, subcortical circuits, and cortical-subcortical interactions are difficult to study with conventional neurophysiologic investigations. Advanced neuroimaging techniques are emerging as leading tool to characterize, noninvasively, these structures. Proton magnetic resonance spectroscopy ( 1 H-MRS) allows to estimate the content of specific biochemical compounds in the brain.
Previous works on focal epilepsies demonstrated that 1 H-MRS can detect metabolic dysfunctions in patients with lesional and nonlesional epilepsy. Most of the studies focused on temporal lobe epilepsy found a decrease in the neuroaxonal marker N-acetyl-aspartate (NAA) inside the epileptogenic zone, in association with changes in other metabolites levels.
16,17
Statement of Significance Proton MR spectroscopy ( 1 H-MRS) study on patients with sleep-related hypermotor epilepsy (SHE) showing metabolic alterations in cortical mesial structures. The NAA to Cr ratio was significantly reduced in the anterior cingulate cortex and was lower in patients with higher seizure occurrence. These findings could help to understand the pathophysiological process that underlies SHE and may provide new hypotheses that need to be clarified in the ongoing investigations.
So far, few 1 H-MRS studies focused on extratemporal lobe epilepsy. In patients with frontal lobe epilepsy and normal magnetic resonance imaging (MRI), 1 H-MRS documented reduced NAA content in the frontal lobe, 18, 19 but its localizing and lateralizing value is still unreliable. 20 1 H-MRS is a sensitive technique being able to detect abnormal metabolism also in brain areas outside structural abnormalities in patients with focal symptomatic epilepsy. 17, 19 In the present study, we explored SHE patients using 1 H-MRS to assess metabolic alterations to better understand the underlying pathophysiology of this rare epileptic syndrome.
METHODS

Participants
We enrolled all consecutive patients attending the Epilepsy Center of our Institute for clinical follow-up from October 2010 to October 2012. SHE diagnosis was confirmed by video-polysomnographic recording of at least one, but preferably, two major episodes (hyperkinetic or asymmetric bilateral tonic/dystonic seizure). 1 Demographic and clinical parameters such as age, sex, disease duration, semiology (hyperkinetic vs. asymmetrical bilateral tonic/dystonic), seizures frequency (low, ie, seizure free at least during the last 6 months before the MR scan vs. annual/ monthly seizures vs. high frequency, ie, multiple per night or weekly), and therapy, were assessed for all patients. To assess the seizure frequency related to the day of brain MR examination, patients and caregivers had been asked to record a diary with the occurrence of seizures in the 6 months before the study.
A group of healthy control volunteers, matched for sex and age, was also recruited. All controls were screened for parasomnia with ad hoc questioner. 21 No control subject meeting the criteria of parasomnia. 22 All patients and controls provided written informed consent for the protocol study approved by the local ethics committee (September 16, 2010).
Brain MR Evaluation
All brain MR scans were performed at the "Functional MR Unit" of the Policlinico S. Orsola-Malpighi, Azienda Ospedaliera-Universitaria, Department of Biomedical and Neuromotor Sciences, University of Bologna.
Each participant underwent a standardized MR protocol using a 1.5 T GE Signa Horizon LX system, equipped with an eight channel phased array head coil, including the following sequences: T1-weighted volumetric FSPGR, Fast SPoiled GRadient echo, (TR, repetition time /TE, echo time = 12.3/5.2 ms and 1 mm isotropic resolution); axial T2-weighted FLAIR, Fluid-attenuated Inversion Recovery, (TR/TE = 8000/85 ms, TI, inversion time = 2000 ms, FOV, field of view = 24 cm, 256 × 256 in-plane resolution, 3-mm slices), coronal T2-weighted FSE, Fast Spin Echo (TR ranging from 5600 to 6500 ms depending on the slices' number, TE = 107 ms, FOV = 24 cm, 256 × 256 in-plane resolution, 4-mm slices).
The protocol included two 1 H-MR spectra acquisitions using the Point RESolved Proton spectroscopy single-voxel localization sequence (PRESS) with chemical shift selective imaging sequence for water suppression. One voxel was selected to include the mesial bilateral anterior cingulate cortex (TR = 4000 ms; TE = 35 ms; VOI, volume of interest = 6 mL; number of acquisitions = 128) ( Figure 1A ) and one in the bilateral-medial thalamus, including the dorsomedial thalamus (TR = 4000 ms, TE = 35 ms, VOI = 5.8 ± 0.6 mL, depending on anatomy, number of acquisitions = 128) ( Figure 1B ). 23 We did not acquire additional spectra in the orbitofrontal cortex, the dorsolateral frontal cortex, or other subcortical structures, due to the limited time acquisition and the high probability of susceptibility artifacts in these structures.
Brain MR Data Analyses
Brain MR images and spectra from all participants were independently visually evaluated by three raters, expert in neuroimaging (RL, CaT, ClT), blind to the clinical condition.
MR Spectroscopic Data Analysis
Peak integrals for NAA, creatine-phosphocreatine (Cr), choline-containing compounds (Cho), and myo-inositol (mI) were calculated using the operator-independent fitting program LCModel with standard basis sets. 24, 25 Figure 1-Localization of proton MRS volume of interest in the anterior cingulate cortex (A) (TR = 4000 ms; TE = 35 ms; VOI, volume of interest = 6 mL; number of acquisitions = 128) and in the medial thalamus (B) (TR = 4000 ms, TE = 35 ms, VOI = 5.8 ± 0.6 mL, depending on anatomy, number of acquisitions = 128) on sagittal and axial view of the 3D FSPGR T1 sequence from a healthy control. FSPGR = Fast SPoiled GRadient echo; MRS = magnetic resonance spectroscopy; TE = echo time; TR = repetition time.
Content values for each metabolite were expressed relative to Cr. The exclusion criterion for metabolite evaluation was an LCModel estimated fitting error >20%, this being a reliable indicator of poor quality spectra.
Statistical Analysis
Statistical analyses were performed using SPSS 21.0 for Windows. The difference in sex distribution between patients and healthy controls was evaluated with chi-square test and in age at MR examination with Student t test. Parametric tests were used to compare spectroscopic variables as KolmogorovSmirnov testing showed that they were normally distributed. Accordingly, differences in metabolites' ratios (NAA/Cr, Cho/ Cr, and mI/Cr) in the anterior cingulate cortex and bilateral-medial thalamus, between SHE patient and control groups were assessed by using the Student t-test for unpaired samples. Significance was set at p values <.05, after Bonferroni correction for multiple comparisons. To test the accuracy to discriminate the two group of participants by spectroscopic data, we used receiver operating characteristic curves.
To evaluate the effect of demographic and clinical parameters such as sex, age, disease duration, semiology (hyperkinetic vs. asymmetrical bilateral tonic/dystonic), seizure frequency (low frequency, ie, seizure free at least during the last 6 months before the MR scan or annual/monthly seizures, vs. high frequency, ie, multiple per night or weekly), and therapy intake on the 1 H-MRS parameters that appeared significantly different between groups, we used a multiple linear regression with a backward stepwise method to obtain the most significant statistic model in which all the included variables had a p-value <.05.
RESULTS
Study Sample
Nineteen SHE patients (seven males; 34.7 ± 9.7 years, mean age ± standard deviation [SD]; 20-50 years, range) and 17 matched healthy volunteers (seven males; 34.0 ± 8.9 years, mean age ± SD; 19-52 years, range) agreed to participate to the study. Mean age was similar in patients and controls (p = .82).
Clinical Features
The clinical features of the SHE patients are detailed in Table 1  and Supplementary Table. The mean age at the onset of epilepsy was 12.3 years (range 3-26) with a mean duration of illness of 23.6 years (range 0-39). In two patients, probable epileptogenic zone was in insular-parietal lobe, in one patient in frontoinsular area, and in one patient in frontotemporal lobe. In three patients, some clinical or electrical features pointed to a presumed frontotemporal onset.
At the time of the 1 H-MRS study, five patients (26.3%) had been seizure free of at least 1 year, five patients (26.3%) had annual or monthly seizures, only one patient (5.3%) presented two-three seizures per week, and eight patients (42.1%) had seizures every night. All but one (Patient 17, Table 1 ) were on mono or polytherapy with antiepileptic drugs. Table 1 ). The spectra of this patient was similar to that of the other patients with higher seizure occurrence and normal MRI (see below).
Brain Conventional MRI Findings
Brain MR examinations did not disclose signal or intensity changes in the SHE patients except for focal cortical dysplasia in the right superior frontal and superior precentral sulcus in one case (Patient 6,
Proton MRS Findings
The NAA-to-Cr ratio was significantly reduced in the anterior cingulate cortex in patients compared to controls (p < .05) (Table 2, Figure 2, Supplementary Figure) . In thalamus, no differences were found in the NAA-to-Cr ratio between patients and controls (Table 2) . Cho/Cr and mI/Cr were similar in patients and controls in both anterior cingulate cortex and thalamus (Table 2) . Cingulate NAA/Cr ratio allowed the discrimination between SHE patients and healthy controls with a sensitivity of 0.765 and a specificity of 0.632 (AUC [95% confidence interval] = 0.765 [0.603-0.927] using a cutoff of 1.244).
On the basis of seizure frequency, 10 patients were included in the group with low seizure frequency and 9 in the group with high seizure frequency.
Regression analysis showed that the NAA/Cr ratio in the anterior cingulate gyrus was significantly associated only with seizure frequency (beta −0.473; p = .048), being lower in patients with higher occurrence (Figure 3) .
DISCUSSION
This is the first
1 H-MRS study on patients with SHE showing metabolic alterations in cortical mesial structures. The significant reduction of NAA/Cr in the anterior cingulate gyrus in patients compared with controls and its correlation with seizure frequency support the involvement of this cerebral area in the pathogenesis of SHE. This is in agreement with the stereo-EEG studies, which reported the early involvement of anterior cingulate gyrus, by ictal discharge, in most of nocturnal hypermotor seizures (82%). 26 Even if seizure in SHE patients may originate from different cortical areas, they have to spread in frontal lobe to give rise to hypermotor release phenomenon as final pathway. 13 The anterior-cingulate NAA reduction observed in our patient, despite a probable extrafrontal epileptogenic zone in some of them, confirms a common frontal alteration in SHE patients. From this point of view, we could speculate that 1 H-MRS does not help to discriminate frontal or extrafrontal epileptogenic zone in SHE patients. However, we placed VOIs based on a pathophysiological a priori hypothesis and we did not explore in the single-patient different cortical areas, following single anatomo-electro-clinical correlation; therefore, we could not asses the localizing/lateralizing value of 1 H-MRS in SHE patients. Although the limited localizing power, the cingulate NAA reduction could be useful to discriminate between SHE patients and participants with parasomnias. This possibility could be the focus of specific studies.
Reduction in NAA content in the epileptogenic zone or in the epileptic network has been reported in many studies, [16] [17] [18] [19] [27] [28] [29] but the exact significance of this data is still debated.
NAA is a biomarker for neuroaxonal integrity and density being present in the mature central nervous system only in neurons, axons, and dendrites but not in glial cells. 30, 31 The Cr signal visible to proton MRS is the sum of creatine and phosphocreatine, and it is used as an internal standard, SLEEP, Vol. 40, No. 9, 2017 Proton MR Spectroscopy in Patients With SHE-Naldi et al.
being its concentration relatively constant in central nervous system disorders. 29 The reduction of NAA/Cr ratio has been found to be associated both with neuronal/axonal loss, such as in hippocampal sclerosis or brain trauma and with normal-appearing areas studied with volumetric MR. 29, [32] [33] [34] Reduced NAA content typically reflects a neuronal loss or damage as detected in neurodegenerative, inflammatory, vascular, or neoplastic disorders. 35 Even if NAA/Cr ratio decrease observed in our patients could indeed reflect neuronal/axonal loss, NAA reduction may also reflect neuronal dysfunction. NAA is synthesized by mitochondria and mitochondrial dysfunction or increased energy demand, can result in reduced neuroaxonal NAA levels. [34] [35] [36] [37] [38] Functional NAA changes have been reported in patients with temporal lobe epilepsy, as indicated by ipsilateral and contralateral NAA recovery after surgery 16, 33 as well as after brain injuries. 39 The reduction of NAA/Cr observed in our patients may reflect a primary energetic impairment of the anterior cingulate gyrus related to epileptic activity, possibly secondary to excitotoxic damage caused by repetitive ictal discharges. Indeed, the MRI of SHE patients is frequently normal, 3 neither our subpopulation of patients revealed structural anomalies in frontal areas, making the hypothesis of neuronal loss unlikely. The hypothesis of a functional NAA/Cr reduction in the anterior cingulate cortex is corroborated by the correlation of its levels with seizure frequency, being lower in patients with very frequent seizures. We could not exclude that the reduction of NAA/Cr may be due to interictal events or subclinic seizures during the 1 H-MRS acquisition, but we argue that this is unlikely as demonstrated by a study showing that the NAA reduction was not an acute effect of seizures but reflected a chronic energetic impairment. 40 It is important to note that the anterior cingulate cortex belongs to the motor inhibition networks. 41 We could speculate that cingulate hypoactivity or dysfunction could facilitate the onset of ictal complex motor behavior due to the release of subcortical Central Pattern Generators according to Tassinari's theory. 13 However, we cannot exclude an unspecific secondary impairment of this brain structure related with repeated epileptic discharges.
We have also studied the medial thalamus to include the mediodorsal nucleus, which is known to be connected to the anterior cingulate cortex. 42 Furthermore, the thalamus is a region often called upon in the genesis of SHE, since seizures occur in the early stages of NREM sleep, and specifically, the EEG discharge onset coincides with physiological sleep H-MR spectra localized in the anterior cingulate cortex (6 mL) obtained from a SHE patient (case no. 3: one of the patients with higher frequency of seizures) (left) and one healthy control (HC) (right). Note the lower peak of NAA (N-acetyl-aspartate), the neuronal marker, in the patient compared to the control participant, while Cr (creatine-phosphocreatine) peaks are similar. transients. 3 Besides, thalamus participates in mesopontine arousal and striatal-dopaminergic system, which are impaired in patients with the genetic form of SHE. 19, 20 However, we found no thalamic alterations. These negative results could be justified by the fact that our thalamic VOI, although mainly included mediodorsal nucleus, probably also included a variable portion of the anterior nucleus or the pulvinar. 43 A different interpretation could be that these regions are not primarily dysfunctional in SHE patients but could amplify abnormal subcortical networks.
The anterior cingulate gyrus seems to be the final common pathway of SHE "network": the frontal/extrafrontal epileptogenic zone, the abnormal subcortical circuits, and the interaction with slow waves sleep concretize their effect on this frontal mesial area and produce complex motor behavior, not referable to the involvement of a unique cortical area.
Although the metabolic abnormality we found in the anterior cingulate cortex is not of unique interpretation, our findings could help to understand the pathophysiological process that underlies SHE and may provide new hypotheses that need to be clarified in the ongoing investigations.
